These compounds may encourage the growth of new neural pathways and influence how chemical messengers behave, contributing to sharper thinking and stronger memory
Experts not involved in AstraZenecas trial say the results are a promising step toward treating type 2 diabetes and obesity
For those seeking more affordable options, there may be alternative treatments available that provide similar benefits
Ongoing monitoring is essential
Therefore, the Food and Drug Administration (FDA) released a guidance requiring all new drugs for glycemic control in T2DM patients to demonstrate cardiovascular safety, a policy that was continued and further emphasized in the 2020 FDA Guidance for Diabetes Drug Development [7, 8]
These medications significantly decrease appetite and promote early satiety, often leading to substantial reductions in daily food consumption